2 Low-Priced Stocks That Could Make You Richer
Buying low-priced growth stocks ($10 or below) can be risky. Companies with bargain-basement share prices tend to have weak balance sheets, highly uncertain outlooks, and limited financing opportunities.
However, this group has also produced an outsize proportion of the market's best-performing stocks over the past 10 years. As such, investors probably shouldn't totally ignore low-priced growth equities, either.
The healthcare sector, for example, has been home to a number of low-priced stocks that eventually went on a major growth spurt. Not that long ago, Axsome Therapeutics and Viking Therapeutics were both sub-$10 stocks. Following key milestone achievements, these biotechs ultimately transformed into two of the best-performing equities in recent memory.
Source Fool.com
